Crispr’s ability to cut genetic code like scissors has just started to turn into medicines. Now, gene editing pioneer Jennifer Doudna wants to build an entire ecosystem to bring these treatments mainstream. #Forbes250 Forbes has named Doudna to our list of America’s 250 Greatest Innovators. Read the full story on the Nobel laureate: